RAM
IONS icon

Readystate Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Readystate Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
+20,436
New +$1.61M 0.07% 181
2025
Q2 		– Sell
-46,394
Closed -$1.4M – 766
2025
Q1 		$1.4M Buy
+46,394
New +$1.52M 0.05% 350
2024
Q3 		– Sell
-5,600
Closed -$267K – 671
2024
Q2 		$267K Buy
+5,600
New +$230K 0.01% 646

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Readystate Asset Management's IONS Position: Q1 2026 in Review

Readystate Asset Management opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 20,436 shares worth $1.53M. The stake represents 0.07% of the portfolio and ranks #181 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in IONS as recently as Q1 2025.

Readystate Asset Management first reported a position in IONS in Q2 2024 and has held it in 3 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Readystate Asset Management held 20,436 shares of Ionis Pharmaceuticals worth $1.53M as of Q1 2026.
  • Ionis Pharmaceuticals was a new Readystate Asset Management position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.07% of Readystate Asset Management's portfolio in Q1 2026, its #181 holding.
  • Readystate Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.